Executive Insights

A few months ago, Gary Miller, Ph.D., gave a commencement speech to the University of Florida’s graduating engineers. It was...

Jean-Paul Burtin was attracted to orthopedics by its possibility for innovation. The enticement did not disappoint....

Obstacles like global supply chain issues and staffing shortages are affecting every player in the market, to varying degrees....

New products and technologies, new global opportunities and competitive hires are top of mind for these leaders....

Monogram Orthopedics seeks to personalize joint replacement through a combination of innovative implants and robotics....

The oversubscribed $12.5 million Series D round sets Catalyst to expand product lines and build out its infrastructure to support...

While autologous live cell therapies are not new, Royal Biologics is creating a unique value proposition through its growing ALC...

Technology updates, the competitive landscape and surgeon and patient interest are pushing orthopedic companies to speed robotic iterations and innovations....

Second-quarter commentary from ortho executives focused on acquisitions, knee replacement sales performance and enabling technology’s impact....

The differences between the hospital and ASC setting are vast and present a learning curve for those managing, operating in...